Journal of Cardiovascular Pharmacology

OCTOBER 9, 2024

Patients in the combination AP +AC therapy group had a higher prevalence of CAD, myocardial infarction, and coronary/vascular stent placement compared to the AC monotherapy group.

Atrial Fibrillation 40

Atrial Fibrillation Myocardial Infarction Kidney Disease Stent 40

Cardiometabolic Health Congress

JULY 17, 2024

February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes. The label includes a “black box” warning for CV risk due to blood clots.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Defibrillator 59

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

Measuring eGFR and albuminuria is recommended for assessing kidney disease in all hypertensive patients. Below are some of the most notable highlights: 2024 ESC Updated Clinical Guidelines: Key updates include clopidogrel as a first-line option for long-term use after MI or PCI.

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59

Dr. Smith's ECG Blog

APRIL 8, 2016

He also had a history of chronic kidney disease, stage III. Angio had shown some acute disease in the saphenous vein graft to the posterior descending artery off of the RCA. This was stented. Most recent echo showed EF of 60%. He had recently had a NonSTEMI. He was managed medically with Clopidogrel.

STEMI 52

STEMI Myocardial Infarction Cardiac Arrest Arrhythmia 52

Stroke Journal

FEBRUARY 1, 2024

SD, 7.7]), 1,635 (2.3%) underwent concomitant intracranial stenting (44% women; mean age, 64.8 [SD, Characteristics associated with intracranial stent utilization were male sex, history of diabetes, hypertension, or chronic kidney disease, absence of atrial fibrillation or CHF, and southern US region. 5.96], P=0.02).Conclusions:In

Stent 40

Stent Stents Strokes Stroke 40

Open Heart

APRIL 28, 2022

Cohorts A and B were well matched with respect to age (69±11 vs 70±12 years; p=0.843), sex (males: 13 of 24 (54%) vs 31 of 44 (70%); p=0.179) and renal function (chronic kidney disease: 1 of 24 (4%) vs 4 of 44 (9%); p=0.457).

Angioplasty 52

Angioplasty Outcomes Stent Stents 52

Open Heart

OCTOBER 21, 2022

Perforation risk factors derived using meta-regression were female sex, hypertension, chronic kidney disease and previous coronary bypass grafting. Covered stents were used to treat 25% of perforations, with emergency cardiac surgery needed in 17%. PROSPERO registration number CRD42020207881.

Outcomes 52

Outcomes Stent Stents Kidney Disease 52